Medtronic plc 8-K

What Happened Medtronic plc filed a Form 8-K on June 3, 2026 (Item 2.02) to announce its fiscal 2026 fourth-quarter and full-year financial results. The company furnished a press release with those results as Exhibit 99.1 to the 8-K. The report was signed by Thierry Piéton, Executive Vice President and Chief Financial Officer.

Key Details

• Filing date: June 3, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Announcement: Press release reporting Medtronic’s Q4 and full-year fiscal 2026 financial results (furnished as Exhibit 99.1).
• Administrative filings: Cover Page Interactive Data File (Inline XBRL) included (Document 104).
• Authorized signature: Report signed by Thierry Piéton, EVP & Chief Financial Officer.

Why It Matters This 8-K formally communicates Medtronic’s reported quarterly and annual earnings to the market. Investors should review the furnished press release and the company’s accompanying financials/XBRL data for revenue, earnings, guidance, and any commentary on business segments — these items can affect valuation, analyst expectations, and short‑term stock moves. The 8-K itself does not include detailed line‑item figures in the filing text; see Exhibit 99.1 for the full financial results.